More on IMCR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+75.0% Growth)
- Ratings (7.6 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Immunocore (NQ:IMCR)
Delayed: 28.60 +0.05 (0.18%)
Prev. Close $28.55  
Open$28.76 
52 Wk High$ 
52 Wk Low$ 
Day High$29.00 
Day Low$28.29 
P/E N/A  
EPS$ 
Volume812,334 

Friends, Peers and Foes (?): ALXN, ACLX, AGIO, AKRO, ASND (more...)

May 31, 2026 08:00 AM Immunocore reports Phase 1 trial results for melanoma treatment brenetafusp
May 31, 2026 08:00 AM Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Peterson Kristine
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Ratcliffe Peter John
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Pao William
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Kaul Siddharth
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Herbst Roy Steven
May 28, 2026 07:55 PM Form 4 Immunocore Holdings plc For: May 27 Filed by: Bell John Irving
May 27, 2026 04:22 PM Form 8-K Immunocore Holdings plc For: May 27
May 22, 2026 03:44 PM Form 144 Immunocore Holdings plc Filed by: Berman David M
View All Articles

Entities mentioned with IMCR

View All Entities